PMID- 15101494
OWN - NLM
STAT- MEDLINE
DCOM- 20040702
LR  - 20191108
IS  - 1098-3597 (Print)
IS  - 1873-4480 (Linking)
VI  - 5
IP  - 4
DP  - 2003
TI  - Esophageal complications of gastroesophageal reflux disease: presentation, 
      diagnosis, management, and outcomes.
PG  - 41-8; discussion 49-50
AB  - The esophageal complications of gastroesophageal reflux disease include peptic 
      esophageal erosion and ulceration, peptic esophageal strictures, and Barrett's 
      esophagus. Endoscopy is the diagnostic procedure of choice for the initial 
      evaluation of lesions. For most patients, symptoms can be controlled with proton 
      pump inhibitor (PPI) therapy. PPIs are also highly effective for healing 
      esophageal erosions and ulcerations and for preventing recurrence of peptic 
      esophageal strictures. Because Barrett's esophagus predisposes individuals to 
      esophageal adenocarcinoma, these patients are advised to have regular endoscopic 
      surveillance to detect early, curable neoplasms.
FAU - Spechler, Stuart Jon
AU  - Spechler SJ
AD  - Division of Gastroenterology, Dallas Veterans Affairs Medical Center, Texas 
      75216, USA. SJSpechler@aol.com
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Clin Cornerstone
JT  - Clinical cornerstone
JID - 9816002
RN  - 0 (Proton Pump Inhibitors)
SB  - IM
MH  - Barrett Esophagus/etiology
MH  - Esophageal Diseases/diagnosis/drug therapy/*etiology/surgery
MH  - Esophageal Stenosis/etiology
MH  - Esophagoscopy
MH  - Gastroesophageal Reflux/*complications/pathology
MH  - Humans
MH  - Proton Pump Inhibitors
RF  - 46
EDAT- 2004/04/23 05:00
MHDA- 2004/07/03 05:00
CRDT- 2004/04/23 05:00
PHST- 2004/04/23 05:00 [pubmed]
PHST- 2004/07/03 05:00 [medline]
PHST- 2004/04/23 05:00 [entrez]
AID - S1098-3597(03)90098-6 [pii]
AID - 10.1016/s1098-3597(03)90098-6 [doi]
PST - ppublish
SO  - Clin Cornerstone. 2003;5(4):41-8; discussion 49-50. doi: 
      10.1016/s1098-3597(03)90098-6.